Survival Predictors in Pulmonary Arterial Hypertension Patients Undergoing Balloon Pulmonary Angioplasty

Authors

  • Farhat Ullah Khan Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
  • Zeeshan Afzal Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
  • Syed Ahsan Akhtar Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
  • Muhammad Hafeez Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
  • Tashfeen Irtaza Khan Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i4.1213

Keywords:

Chronic Thromboembolic Pulmonary Hypertension, Balloon Pulmonary Angioplasty, Pulmonary Arterial Hypertension, Survival Predictors, Hemodynamics

Abstract

Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe complication of pulmonary embolism that leads to progressive right heart failure and death if untreated. Balloon pulmonary angioplasty (BPA) has emerged as a promising intervention for patients with inoperable or residual disease post-pulmonary endarterectomy. Objective: To identify predictors of short-term survival in pulmonary arterial hypertension patients undergoing BPA. Materials and Method: This prospective observational study was conducted at Department of Cardiology, Hayatabad Medical Complex, Peshawar from January, 2023 to June 2023. Fifty-two patients with confirmed inoperable or residual CTEPH underwent BPA. Hemodynamic and clinical parameters were assessed pre- and post-procedure, and survival was evaluated at six months. Results: Survival at six months was 88.5%. Post-procedural mean pulmonary artery pressure <35 mmHg, baseline cardiac index ≥2.0 L/min/m², and absence of vascular injury during BPA were independent predictors of survival. Significant improvements were observed in mPAP, PVR, and WHO functional class. Conclusion: BPA significantly improves survival and clinical status in selected PAH patients. Early hemodynamic response and procedural safety are key survival predictors.

Downloads

Download data is not yet available.

References

Ito, R., Yamashita, J., Ikeda, S., Nakajima, Y., Kasahara, T., Sasaki, Y., Suzuki, S., Takahashi, L., Komatsu, I., Murata, N. and Shimahara, Y., 2023. Predictors of procedural complications in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Journal of Cardiology, 82(6), pp.497-503.

https://doi.org/10.1016/j.jjcc.2023.06.011

Piliero, N., Thony, F., Guillien, A., Rousseau, J., Finas, M., Vautrin, E., Degano, B. and Bouvaist, H., 2022. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: evaluation of haemodynamic effects, complication rates and radiation exposure over time. Archives of cardiovascular diseases, 115(5), pp.295-304.

https://doi.org/10.1016/j.acvd.2022.02.010

Kennedy, M.K., Kennedy, S.A., Tan, K.T., de Perrot, M., Bassett, P., McInnis, M.C., Thenganatt, J., Donahoe, L., Granton, J. and Mafeld, S., 2023. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. Cardiovascular and interventional radiology, 46(1), pp.5-18.

https://doi.org/10.1007/s00270-022-03323-8

Li, X., Zhang, Y., Jin, Q., Luo, Q., Zhao, Q., Yang, T., Zeng, Q., Yan, L., Duan, A., Huang, Z. and Hu, M., 2022. Predictors of early response to balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Therapeutic Advances in Respiratory Disease, 16, p.17534666221138001.

https://doi.org/10.1177/17534666221138001

Yang, K.M., Wang, M.T., Tao, C.W., Wu, Y.J., Hsu, C.H., Liao, W.C., Hsu, H.H., Lin, M.C., Tsai, F.T., Fu, Y.J. and Kuo, F.Y., 2024. The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty. Journal of the Chinese Medical Association, 87(3), pp.273-279.

https://doi.org/10.1097/jcma.0000000000001059

Daigo, K., Katsumata, Y., Esaki, K., Iwasawa, Y., Ichihara, G., Miura, K., Shirakawa, K., Sato, Y., Sato, K. and Fukuda, K., 2023. Predictors of improvement in exercise tolerance after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Journal of the American Heart Association, 12(3), p.e8137.

https://doi.org/10.1161/jaha.122.027395

Xin, L., Zhang, Y., Luo, Q., Zhao, Q., Yang, T., Zeng, Q., Jin, Q., Duan, A., Huang, Z., Hu, M. and Zhang, S., 2023. Development and validation of a nomogram for predicting hemodynamic response to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Respiratory Medicine, 220, p.107440.

https://doi.org/10.1016/j.rmed.2023.107440

Darocha, S., Roik, M., Kopeć, G., Araszkiewicz, A., Furdal, M., Lewandowski, M., Jacheć, W., Grabka, M., Banaszkiewicz, M., Pietrasik, A. and Pietura, R., 2022. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry. EuroIntervention, 17(13), p.1104.

https://doi.org/10.4244/eij-d-21-00230

Ejiri, K., Ogawa, A., Shimokawahara, H. and Matsubara, H., 2022. Treatment of vascular injury during balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. JACC: Asia, 2(7), pp.831-842.

https://doi.org/10.1016/j.jacasi.2022.08.011

Taniguchi, Y., Matsuoka, Y., Onishi, H., Yanaka, K., Emoto, N., Nakai, H., Okada, K. and Hirata, K., 2021. The role of balloon pulmonary angioplasty and pulmonary endarterectomy: Is chronic thromboembolic pulmonary hypertension still a life-threatening disease?. International Journal of Cardiology, 326, pp.170-177.

https://doi.org/10.1016/j.ijcard.2020.10.026

Delcroix, M., Pepke-Zaba, J., D’Armini, A.M., Fadel, E., Guth, S., Hoole, S.P., Jenkins, D.P., Kiely, D.G., Kim, N.H., Madani, M.M. and Matsubara, H., 2024. Worldwide CTEPH registry: long-term outcomes with pulmonary endarterectomy, balloon pulmonary angioplasty, and medical therapy. Circulation, 150(17), pp.1354-1365.

https://doi.org/10.1161/circulationaha.124.068610

Mahmud, E., Patel, M., Ang, L. and Poch, D., 2021. Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Pulmonary Circulation, 11(2), p.20458940211007385.

https://doi.org/10.1177/20458940211007385

Kallonen, J., Korsholm, K., Bredin, F., Corbascio, M., Jønsson Andersen, M., Ilkjær, L.B., Mellemkjær, S. and Sartipy, U., 2022. Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Pulmonary Circulation, 12(2), p.e12093.

https://doi.org/10.1002/pul2.12093

Masaki, K., Hosokawa, K., Funakoshi, K., Taniguchi, Y., Adachi, S., Inami, T., Yamashita, J., Ogino, H., Tsujino, I., Hatano, M. and Yaoita, N., 2024. Outcomes of chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty and pulmonary endarterectomy. JACC: Asia, 4(8), pp.577-589.

https://doi.org/10.1016/j.jacasi.2024.05.007

Fujii, S., Nagayoshi, S., Ogawa, K., Muto, M., Tanaka, T.D., Minai, K., Kawai, M. and Yoshimura, M., 2021. A pilot cohort study assessing the feasibility of complete revascularization with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. PLoS One, 16(7), p.e0254770.

https://doi.org/10.1371/journal.pone.0254770

Downloads

Published

2025-04-30

How to Cite

Survival Predictors in Pulmonary Arterial Hypertension Patients Undergoing Balloon Pulmonary Angioplasty. (2025). Indus Journal of Bioscience Research, 3(4), 759-764. https://doi.org/10.70749/ijbr.v3i4.1213